OrthoPediatrics Corp (NASDAQ:KIDS) Q3 2022 Earnings Conference Call November 1, 2022 8:00 AM ET
Company Participants
Emma Poalillo - Gilmartin Group
David Bailey - President, CEO & Director
Fred Hite - CFO, Principal Financial & Accounting Officer, COO and Director
Conference Call Participants
Matthew O'Brien - Piper Sandler & Co.
Anton Heldmann - Stifel, Nicolaus & Company
Ryan Zimmerman - BTIG
Samuel Brodovsky - Truist Securities
Michael Matson - Needham & Company
Operator
Good morning, and welcome to OrthoPediatrics Corporation Third Quarter 2022 Earnings Conference Call. [Operator Instructions]. As a reminder, this call is being recorded for replay purposes.
I would now like to turn the call over to Emma Poalillo from the Gilmartin Group for a few introductory comments.
Emma Poalillo
Thank you for joining today's call. With me from the company are David Bailey, President and Chief Executive Officer; and Fred Hite, Chief Operating and Financial Officer.
Before we begin today, let me remind you that the company's remarks include forward-looking statements within the meaning of federal securities laws, including the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to numerous risks and uncertainties, and the company's actual results may differ materially. For a discussion of risk factors, including, among others, the risks related to COVID-19, the impacts this pandemic may have on the demand for the company's products and the company's ability to respond to the related challenges, I encourage you to review the company's most recent annual report on Form 10-K, which was filed with the Securities and Exchange Commission on March 3rd, 2022.
During the call today, management will also discuss certain non-GAAP financial measures, which are supplemental measures of performance. The company believes these measures provide useful information for investors in evaluating its operations period-over-period. For each non-GAAP financial measure referenced on this call, the company has included a reconciliation of non-GAAP financial measures to the most directly comparable GAAP financial measures in its earnings release. Please note that the non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as a substitute for OrthoPediatrics' financial results prepared in accordance with GAAP.
In addition, the content of this conference call contains time-sensitive information that is accurate only as of the date of this live broadcast today, November 1, 2022. Except as required by law, the company undertakes no obligation to revise or update any statements to reflect events or circumstances taking place after the date of this call.